ArticleMedical oncology (Northwood, London, England)2026

KS79356, a novel kynureninase inhibitor, suppresses triple-negative breast cancer progression by attenuating the TNF-α/NFκB-CD44-Akt signaling axis.

Maha Alamodi Alghamdi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.